- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04012437
Efficacy of App and Electronic Device in the Treatment of Premature Ejaculation
Sphincter Control Training Program Using a App and Electronic Medical Device in the Treatment of Premature Ejaculation: Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project of research will use one experimental groups, It will manage the affairs the therapy "sphincter control training" (SCT) into app combined with the external device called Myhixel I .Experimental groups will receive therapy with the protocol of exercises SCT.
The main measure will be the "fold increase" (FI) of the IELT, which was calculated using the geometric mean of post-treatment IELTs (period B) divided by the geometric mean of pre-treatment IELTs (period A): FI = (geometric mean of IELT_7wk)/(geometric mean of PRE_IELT)
The efficiency on the EP will see (IELT) reflected in an increase in the times of latency of intravaginal ejaculation and in punctuations of subjective perception, of the therapy on the line base.
The subjects that will be born in mind will be all the interested parties in informing that their answer to the campaign of national advertising that will be started.
The duration of the treatment will be 8 weeks during which a series of exercises app will be practised usin the masturbation device Myhixel I.
The material used in the research will be innocuous and his responsible use does not produce adverse reactions of interest.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Murcia, Spain, 30007
- Jesús Rodríguez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged over 18 years.
- Being in a heterosexual relationship for at least the last 6 months.
- Having a score of >11 on the Premature Ejaculation Diagnostic Tool (PEDT).
- Having a self-reported IELT ≤2 minutes.
Exclusion Criteria:
- A history of alcohol abuse or dependence.
- Having received medication or psychological treatment for PE in the last 6 months.
- Having diabetes.
- The regular use of recreational drugs (except tobacco and caffeine).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
.The groups completed Sphincter Control Training over 8 weeks.
The SCT consists of 8 different exercises into a mobile app and an educational videos.
Its objective is to provide patients with greater knowledge, awareness, and control of the external urethral sphincter.
The groups use of a masturbation aid device called Myhixel I from the spanish company New Wellness Concept SL.
|
The SCT + device consists of 8 different exercises and an educational session into a app using a masturbation electronic aid device
|
|
Active Comparator: Control
.The groups completed Sphincter Control Training over 8 weeks.
The SCT consists of 8 different exercises into a video tutorial and an educational videos.
Its objective is to provide patients with greater knowledge, awareness, and control of the external urethral sphincter.
|
The SCT consists of 4 different exercises and an educational session into a app using a masturbation electronic aid device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IELT FOLD INCREASE
Time Frame: 10 weeks
|
The main measure will be the "fold increase" (FI) of the IELT, which was calculated using the geometric mean of post-treatment IELTs (period B) divided by the geometric mean of pre-treatment IELTs (period A): FI = (geometric mean of IELT_7wk)/(geometric mean of PRE_IELT)
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PEDT
Time Frame: 10 weeks
|
The test-retest reliability of the PEDT is .82,
and all items discriminate in a statistically significant way between patients with PE and without PE, with a cut-off score for the diagnosis
|
10 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISM-SCT-2019-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Ejaculation
-
BioprojetRecruitingPremature (Early) EjaculationFrance
-
Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological | EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Ejaculation
-
Sohag UniversityCompletedVitamin D, Vitamin B12 and Folic Acid Among Patients With Premature EjaculationEgypt
-
Al Mouwasat HospitalCompletedPremature (Early) EjaculationSaudi Arabia
-
Başakşehir Çam & Sakura City HospitalNot yet recruitingPremature Ejaculation | EjaculationTurkey (Türkiye)
-
PfizerCompletedEjaculationUnited States
-
Abant Izzet Baysal UniversityCompletedEjaculatory Dysfunction | Sexual Dysfunction Male | Premature (Early) EjaculationTurkey (Türkiye)
-
PfizerCompletedEjaculationUnited States, Australia, Canada, United Kingdom
-
PfizerCompletedEjaculationItaly, Spain, Australia, Austria, Canada, Czech Republic, France, Germany, Israel, Norway, Poland, Sweden, Turkey, Netherlands
Clinical Trials on Sphincter Control Training (SCT)
-
University of PittsburghNational Institute of Nursing Research (NINR); University of IowaCompleted
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingSelf-compassion Training (SCT) Plus Intranasal Oxytocin | Self-compassion Training (SCT) Plus Intranasal PlaceboSpain
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)Completed
-
Virginia Polytechnic Institute and State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Universidade Federal de PernambucoNot yet recruitingGastroesophageal Reflux Disease (GERD)Brazil
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
University GhentLithuanian University of Health Sciences; VU University of AmsterdamCompletedSexual and Reproductive Health ProblemsBolivia, Ecuador, Nicaragua
-
Herlev HospitalUnknownFecal Incontinence | Anal IncontinenceDenmark
-
University GhentCompletedMajor Depression in RemissionBelgium
-
Tel Aviv UniversityCompleted